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ABSTRACT
￿
In addition to containing microtubule and microfilament systems, vertebrate epi-
thelial cells contain an elaborate keratin intermediate-filament cytoskeleton . Little is known
about its structural organization or function . Using indirect immunofluorescence microscopy
with an antikeratin antiserum probe, we found that destabilization of microtubules and
microfilaments with cytostatic drugs induces significant alterations in the cytoskeletal organi-
zation of keratin filaments in HeLa and fetal mouse epidermal cells . Keratin filament organi-
zation was observed to undergo a rapid (1-2 h) transition from a uniform distribution to an
open lattice of keratin fibers stabilized by membrane-associated focal centers . Since addition
of any one drug alone did not elicit significant organizational change in the keratin cyto-
skeleton, we suggest that microfilaments and microtubules have a combined role in maintain-
ing the arrangement of keratin in these cells . Vimentin filaments, the only other intermediate-
sized filaments found in HeLa cells, did not co-distribute with keratin in untreated or drug-
treated cells . These findings offer a new way to approach the study of the dynamics and
functional roles of the keratin cytoskeleton in epithelial cells .
The structure and function of the vertebrate cytoskeleton are
dependent upon three major groups of polymers : microtu-
bules, microfilaments, and intermediate filaments . Unlike
microtubules and microfilaments, whose distributions are
universal in vertebrate cells and whose functions are well
characterized (1-4), intermediate filaments are generally re-
stricted in distribution to specific cell types, and their func-
tions remain unresolved (5, 6) . Lazarides (5) has suggested
that they participate in the organization and mechanical
integration of the cytoplasm . Attention has recently focused
on elucidating the structure, function, and organization of
keratins in epithelial cells, particularly their utilization as
elements of an intermediate-filament cytoskeleton where they
are designated `cytokeratins' (7-10) .
Keratin filament organization has been shown to be re-
markably stable in epithelial cells in vitro by immunological
methods (10, 13, 14) . Microinjection of anti-a-keratin anti-
bodies into epithelial cells has been used to directly alter the
organization of the keratin cytoskeleton (11, 12) . However,
no biochemical inhibitors analogous to cytostatic drugs used
to destabilize microtubules or microfilaments have been
found that specifically interfere with cytokeratin structure or
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function (6) . Recent immunofluorescence studies of cytoker-
atins during mitosis in certain epithelial cell types, including
HeLa cells, have demonstrated that the otherwise immutable
organization of cytokeratins changes from an extended fila-
mentous arrangement to a condensed, spheroidal form as the
cells divide, with the re-establishment of extended filaments
following division (15, 16). This transformation suggests that
there are specific mechanisms for the alteration of cytokeratin
organization that may be dependent on, or triggered by,
changes in the organization of microfilaments and microtu-
bules. Since microfilaments and microtubules are rearranged
during cell division in order to complete karyokinesis and
cytokinesis, we have investigated the possibility that the or-
ganization of cytokeratins in interphase HeLa cells can be
altered experimentally by drug-induced changes in the struc-
ture and organization of both microfilaments and microtu-
bules . Previous studies, testing individual cytostatic drugs,
have shown them to be relatively ineffective in altering the
distribution ofcytokeratin . Disruption ofmicrofilaments with
cytochalasins (10, 17) or microtubules by colchicine deriva-
tives (13, 17) does not significantly alter the inherent organi-
zation of cytokeratins . However, a dramatic reorganization of
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epithelial cell types (17) after combined treatment of cells
with cytochalasins, colchicine, and related compounds. The
induction of a number of novel structural rearrangements in
the keratin cytoskeleton ofHeLa and fetal mouse epidermal
(FME)' cells described in this report provides further evidence
for possible interactions among cytoskeletal elements in the
organization of keratins .
MATERIALS AND METHODS
Cell Culturing
HeLa-S3 cells were obtained from Dr. Clive L . Bunn (University of South
Carolina, Columbia) and maintained in Eagle's minimum essential medium
(Gibco Laboratories, Grand Island, NY) containing nonessential amino acids
and supplemented with 10% fetal bovine serum (KC Biologicals, Lenexa, KN)
plus antibiotics. Cells were subcultivated in Leibovitz's L-15 medium (L-15,
Gibco Laboratories) supplemented with 10% FBS on 15-mm glass coverslips
within individual wells of multi-well culture plates . Cultures were grown for a
minimum of24 h at 37°C and used at subconfluent densities.
FME cells were obtained from the back skin of 14-d-old DBA/2J mouse
fetuses. The epidermiswas separated manually from eachdermis aftertreatment
of pieces ofwhole skin with 3 .3 mg/ml collagenase (Sigma Chemical Co., St .
Louis, MO) for 1 h at 37°C on a gyratory shaker. Isolated epidermis was
dissociated into a cell suspension aftertrypsin treatment(17) . Cells were plated
on 15-mm glass coverslips. FME cells were grown in L-15 medium supple-
mented with 10% fetal bovine serum under culture conditions identical to
those used for HeLa cells .
I M M UN OL OG ICAL PROCE DU R ES :
￿
Cytoskeleton-enriched polypeptide
fractions were extracted using a modification of the Triton X-100-1 .5 M KCI
method (13) developed for HeLa cells (14) . The resulting proteinaceous pellets
were dissolved in sample buffer and separated on 10% polyacrylamide gels at
a pH of8 .3 (18).
For immunoblotting ("Western blotting"), the separated polypeptides were
electrophoretically transferred from the gel to nitrocellulose membranes (19) .
Blotting was evaluated by staining duplicate sections ofnitrocellulose with 1 %
Amido black IOB and comparing them with an equivalent Coomassie Brilliant
Blue-stained portion ofthepolyacrylamide gel . The unstained membraneswere
then reacted with a 1:1000 dilution of rabbit anti-a-keratin antiserum (20) .
Antibody localization of polypeptide bands was achieved by incubating the
membrane in the presence of goat anti-rabbit IgG antibody conjugated with
horseradish peroxidase (Bio-Rad Laboratories, Richmond, CA). Enzyme activ-
ity was detected by reaction with 4-chloro-l-naphthol (21) .
Indirect Immunofluorescence Microscopy
Fixed and permeabilized HeLa orFME cells were rehydrated in Sorenson's
phosphate buffer (pH 7.2-7.4) for 5 min . 100 yl of a 1 :30 dilution of anti-
avian a-keratin antiserum (20) made in rabbits or a corresponding dilution of
preadsorbed antiserum or preimmune serum was applied to cells on each
coverslip. In addition to anti-a-keratin antiserum, antiserums against bovine
prekeratin, actin, tubulin (Miles Laboratories, Inc ., Elkhart, IN), and vimentin
(Transformation Res, Framington, ME) were used to assess the effects ofdrug
treatments on selected elements ofthe HeLa cytoskeleton. Cells on coverslips
were then incubated at 37°C in a humidified chamber for 20-30 min . Cultures
were rinsed extensively in phosphate buffer and then treated with fluorescein-
conjugated goat anti-rabbit IgG (Miles Laboratories Inc .) for 20-30 min at
37°C . They were again rinsed extensively in phosphate buffer, mounted culture-
side down in 10% glycerol on glass slides, and examined by epifluorescence
microscopy .
Drug Treatments
Combinations of different cytostatic drugs used at several concentrations
were tested for effect(s)on the organization ofthe keratin cytoskeleton ofHeLa
and FME cells (Table 1). Stock solutions of cytochalasin B, cytochalasin D,
and ß-lumicolchicine were made up in DMSO . Colchicine, demecolcine (Col-
cemid) and vinblastine sulfate were dissolved in L-15 . All drugs were obtained
from Sigma Chemical Co. Colchicine, demecolcine, and lumicolchicine were
tested at final concentrations ranging from 10' M to l0- 'M (0.4-400, .g/mi) .
Vinblastine was used at the same molar concentrations. Cytochalasin D was
'Abbreviations used in this paper: FME, fetal mouse epidermal
(cells) .
utilized at concentrations ranging from 0.05 to 5 kg/ml . Cytochalasin B was
tested over a concentration range of from 0 .5 to 25 Ag/ml. Parallel cultures of
untreated and DMSO-treated controls were maintained for each series of
experiments. Cell viability during the testing period was determined in all cases
to be >95% by trypan blue dye exclusion. Cells were fixed and permeabilized
as previously described and processed for indirect immunofluorescence .
RESULTS
Electrophoretic transfer of isolated HeLa cell polypeptides
from polyacrylamide gels to nitrocellulose paper and subse-
quent reaction with a-keratin antiserum (Fig. 1) resulted in
the demonstration of principal cross-reaction with one major
human keratin polypeptide band. Indirect immunofluores-
cence microscopy utilizing this antiserum allowed visualiza-
tion of a distinctive pattern of cytoskeletal filaments charac-
teristic of cytokeratins in both HeLa and FME cells. Antise-
rum against mammalian a-keratin allowed visualization of
the same distinctive organization of filaments demonstrated
with antiserum-against aviAn a-keratin .
FIGURE 1 Immunoblot of
Triton X-100, 1 .5 M KCI
insoluble HeLa cell poly-
peptides with antiker-
atin antiserum . (A) SDS
PAGE pattern of cyto-
skeleton-enriched HeLa
cell extracts stained with
Coomassie Brilliant Blue.
(8) Polypeptides electro-
phoretically transferred
from a polyacrylamide
gel to nitrocellulose
and stained with amido
black . (C) Reaction of
antikeratin antiserum
with polypeptides trans-
ferred to nitrocellulose
and detected with per-
oxidase labeled second
antibody. Upper arrow-
heads locate keratin,
lower arrowheads locate
vimentin . The position of
the vimentin band was
determined separately
by immunoblotting pro-
cedures using antivimen-
tin antiserum .
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￿
Indirect immunofluorescence localization of cytokeratin
in an FME cell treated with colchicine and cytochalasin D for 2 h .
Keratin is attached to large, membrane focal centers (arrows) that
organize the filaments into a lattice (see also reference 17) Bar, 10
um . x 685 .
The distribution and arrangement of cytokeratin in a con-
trol culture of HeLa cells that has been reacted with anti-a-
keratin antiserum and visualized using indirect immunoflu-
orescence is shown in Figure 2a. The uniform-sized, wavy-
appearing keratin filaments are evenly distributed throughout
the cytoplasm . This arrangement of evenly distributed, uni-
form-sized filaments is also characteristic of FME cells. The
nucleus of each cell is a centrally located, nonstaining oblate
structure (Fig. 2a) surrounded by keratin filaments . The
filament arrangement observed is typical of the interphase
organization inherent to most cultured epithelial cells in the
unperturbed state (12) . The distribution and arrangement of
other elements ofthe HeLa cell cytoskeleton including micro-
filaments, microtubules, and nonkeratin intermediate-sized
filaments is visualized by indirect immunofluorescence mi-
croscopy using antiserums specific for actin, tubulin, or vi-
mentin, respectively (Fig. 2, b-d) .
The redistribution of cytokeratin filaments in HeLa cells
following a 2-hourtreatment with both 0.5 kg/ml cytochalasin
D and 4 mg/ml colchicine (Fig. 2 c) demonstrates the dramatic
effect of the combination of these two cytostatic drugs. This
treatment also results in reorganization ofcytokeratin inFME
cells (Fig . 3) . The effects of these drugs on the other elements
of the cytoskeleton are shown in Fig . 2, f-h .
Other cytostatic drugs and drug combinations were tested
in HeLa cells for effects on the organization of the keratin
filament cytoskeleton . Cytochalasin B, at a concentration of
10 jug/ml, in combination with colchicine was as effective as
TABLE I
Effect of Cytostatic Drugs on Keratin Cytoskeleton Organization
Drug-induced changes in cytokeratin organization in HeLa or FME cells were
tested with various microtubule- or microfilament-inhibiting compounds . A
dose response for each microtubule or microfilament inhibitor was tested
either alone or in binary combination over a 2-h period . Colchicine, Col-
cemid, vinblastine, and fl-lumicolchicine alone were ineffective in eliciting
changes in cytokeratin organization (0) over a concentration range of 10-6 -
10 -'M. Cytochalasin B (0.5-25 ug/ml) or cytochalasin D (0.05-5 rig/ml) in
1% DMSO elicited a variable and limited response, restricted to the cell
periphery (0°) . Combination of fl-lumicolchicine and cytochalasin D (0.)
resulted in a cytokeratin configuration indistinguishable from that of cyto-
chalasin Dcontrols (O') . fl-lumicolchicine with cytochalasin Bwas not tested
(n .t .) . Combinations of inhibitors at low concentrations (10-6M microtubule
inhibitors with either 0.05 lug/ml cytochalasin Dor 0.5 ug/ml cytochalasin B)
were ineffective in eliciting changes in cytokeratin organization . A graded
increase in the degree of cellular response was observed up to dosages of
10 -°M for microtubule inhibitors with 0.5 rug/ml cytochalasin D or 10 ug/ml
cytochalasin B (+) . Higher concentrations of binary drug combinations elic-
ited not only alterations in cytokeratin organization but also excessive retrac-
tion of spread cells, as well as rounding up and release of cells from the
substratum .
cytochalasin D in inducing keratin rearrangement. Both cy-
tochalasinB and cytochalasinD were effective in combination
with demecolcine or vinblastine sulfate (Table 1). Cytochal-
asin D in combination with fl-lumicolchicine had a markedly
reduced effect on the organization of cytokeratins (Table 1) .
This effect was qualitatively similar to the effect of cytochal-
asins alone, which consistently resulted in surface retraction
at the cell perimeter and limited peripheral reorganization of
the keratin cytoskeleton (17) . fl-lumicolchicine alone had no
discernible morphological effect on keratin organization .
Cytochalasin D and colchicine were selected as representa-
tive microfilament and microtubule inhibitors and used as
the principal combination of drugs for studies reported here .
Optimal concentrations ofcytochalasin D and colchicine were
determined qualitatively from minimum dosages capable of
inducing maximal observable effects on both individual cells
and the number of cells effected in the population .
4 ttg/ml colchicine proved to be the most effective dosage
in combination with 0.5 ug/ml cytochalasin D, in terms of
both the onset of keratin redistribution, which begins within
15-30 min of combined drug treatment, and the greater
percentage ofcells effected within the 2-h treatment time. The
keratin filaments of treated cells are reorganized into an open
lattice arrangement with filament focal centers both on the
basal surface and along the cell periphery (Figs. 2e and 3).
The focal centers appear to maintain the organization of the
filaments after the depolymerization of microfilaments and
microtubules . Microtubule and microfilament organization is
FIGURE 2
￿
Indirect immunofluorescence localization of HeLa cell cytoskeletal elements . Untreated control cells are represented
in a-dand cells treated with colchicine and cytochalasin Dfor 2 h are represented in e-h. Characteristic differences in cytoskeletal
organization are compared for keratin (a and e), actin (b and f), tubulin (c and g), and vimentin (d and h) in the absence and
presence of colchicine and cytochalasin D. N, nucleus . Arrows in e indicate focal sites for keratin filaments . (a) Bar, 10 um . x
1,500 ; (b-d and f-h) bar, 10 um . x 685; (e) bar, 10 um . x 1,800 .
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Microfilament inhibitors
Microtubule Cytochalasin Cytochalasin
inhibitors B D None
Colchicine + + 0
Colcemid + + 0
Vinblastine sulfate + + 0
Lumicolchicine n.t . O
a 0
None Ob Ob 0completely disrupted in HeLa cells following combined drug
treatment (Fig. 2, fand g) . Vimentin filaments show little
discernible change in morphological appearance after com-
bined drug treatment, an appearance which is distinctly dif-
ferent from that of cytokeratins, microtubules, and microfil-
aments (Fig . 2) . Under the conditions of these experiments,
they do not form the perinuclear structures observed after
long-term treatment ofcells with colchicine derivatives . Treat-
ment ofcells for 2 h at 37°C with 4.0 Ag/ml colchicine or 0.5
FIGURE 4
￿
Indirect immunofluorescence localization of cytokeratin
in HeLa cells treated for 2 h with colchicine and cytochalasin D .
The peripheral reorganization of keratin filaments shown in a (ar-
rows) forms a polygonal pattern with a limited number of membrane
attachment sites (double arrows) . Bar, 10 um . x 1,500 . Keratin
polarization in HeLa cells is depicted in b . The majority of the
keratin is present in a core of displaced keratin-positive material .
The nucleus (N) is surrounded by the remainder of the keratin
filaments still attached to membrane sites . Bar, 10 gym . x 2,400 .
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FIGURE 5
￿
Indirect immunofluorescence localization of cytokeratin
in an untreated late mitotic HeLa cell with keratin organized into
spheroidal bodies (arrows) (see also references 15 and 16) . Bar, 10
jum . x 685 .
Ag/ml cytochalasin D alone results in little or no significant
alteration in the inherent distribution ofcytokeratins, though
treatment with cytochalasins alone has a greater effect in
general than treatment with any ofthe microtubule inhibitors.
Cells reacted with preabsorbed anti-a-keratin antiserum or
preimmune serum showed no fluorescence regardless oftreat-
ment .
The star-like configuration of cytokeratin observed in Figs .
2e and 3 is only one of several configurations displayed by
cytochalasin- and colchicine-treated cells . These keratin fila-
ment patterns are also visualized by indirect immunofluores-
cence using anti-mammalian a-keratin antiserum . In some
cases the keratins are organized in a pattern of filaments that
reflects major alignment, with a few peripheral focal attach-
ment sites located at the vertices of polygonal structures (Fig .
4a) . The cytokeratins do not appear to be completely rear-
ranged in the central, perinuclear region of the cytoplasm . In
other cases the majority ofcytokeratin is condensed in a single
region ofthe cell . The filaments appear radially symmetrical,
arising from a central core (Fig. 4 b). The distribution of the
cytokeratins in these cells shows a marked polarity relative to
the position ofthe nucleus . The rest of the keratin cytoskele-
ton, including some membrane attachment sites, remains
associated with the cytoplasm and cellmembrane surrounding
the nucleus . Fig . 5 demonstrates the reorganization ofkeratin
in an untreated dividingHeLa cell . The spheroidal bodies (15,
16) stain intensely with antikeratin antiserum .
DISCUSSION
Extensive rearrangement of keratin filament organization is
observed in HeLa and FME cells after combined drug treat-
ment (Figs. 2eand 3) . A lattice offilaments occurs throughout
the cytoplasm, and filament-organizing sites are clearly ob-
served at the cell perimeter and over the basal cell surface
(Figs . 2e, 3, and 4). The spherical accumulation of keratin-
positive material at these foci results from the overlap ofthese
sites and/or an accumulation of filamentous keratin into a
condensed form that remains associated with them . A less
frequently observed arrangement of keratin filaments in
treated cells, and one restricted to smaller cells, involves
incomplete transformation of cytokeratins in the interior
regions of the cytoplasm. The reorganization of cytokeratins
in these cells results in the formation of simple polygonal
arrangements with filaments or groups of filaments stretchedbetween the vertices (Fig. 4a). This configuration could result
from a realignment of the filaments potentially involved in
maintaining epithelial cell morphology. In the absence of
microfilaments and microtubules, cytokeratins and their
membrane attachment sites could provide a major stabilizing
network in the cells. Nuclear membrane sites for association
with or organization of keratin filaments have also been
proposed to be involved in stabilizing the organization of
cytokeratins (12). Displacement of keratin filaments, similar
in extent to that seen in Figure 4b, has been induced by
cytoplasmic microinjection of antikeratin antibodies into
other epithelial cell types (11). In this context, there is a nearly
complete polarization of keratin distribution in a small num-
ber of cells (Fig. 4b). Instability of membrane attachment
sites and/or disruption of filament interactions with the nu-
cleus may be involved. A small portion of the keratin fila-
ments remain in the perinuclear cytoplasm with attachment
sites at the cell membrane, but most ofthe keratin is displaced
and condensed in a single core structure with filaments or
loops of filaments extending radially from it (Fig. 4b). It
appears that combined drug treatment can indirectly induce
alterations in keratin-membrane and keratin-nucleus inter-
actions similar to those observed after microinjection of se-
lected antikeratin antibodies (11).
Horwitz et al. (15) and, more recently, Franke et al. (16)
show that HeLa cells can regulate keratin organization from
a filamentous form to condensed, multiple spheroidal ar-
rangements during different phases of the mitotic cycle (Fig.
5). Cytokeratin organization in HeLa cells can also be mod-
ulated by a combination of the cytostatic drugs colchicine
and cytochalasin D, as well as related cytostatic compounds,
with similar physiological effects (Table 1). This cellular re-
sponse to a diversity of related but not identically acting
compounds reinforces the suggestion that organization of
microtubules and microfilaments influences the distribution
of cytokeratins on epithelial cells. However, the drug-induced
keratin filament reorganization differs somewhat in nature
from that of mitotic rearrangements (Figs. 2 e, 3, and 5).
Mouse squamous cell carcinoma cells and primary cultures
of FME cells also show this response to combined drug
treatment (17; Fig. 3). It is of considerable importance to note
that this reorganization of keratin filaments also takes place
in primary cultures of FME cells, which lack vimentin fila-
ments entirely (5, 17). This demonstrates the independence
ofthe organization ofkeratin filaments under these conditions
from other intermediate filaments (e.g. vimentin) present in
HeLa cells. In addition, the immunological cross-reaction of
antiserum to avian a-keratin with Triton X-100-KCI-insolu-
ble extracts of HeLa cell polypeptides in Western blots (Fig.
1) demonstrates that the primary reactivity is to a keratin
polypeptide (M, - 56,000), with limited reactivityto several
other keratin polypeptides. There is no detectable cross-reac-
tion of vimentin with antikeratin antiserum (Fig. 1).
The various organizational configurations of cytokeratins
in HeLa cells induced by combined drug treatment (Figs. 2 e
and 4) appear different from the spherical bodies seen in
normal, dividing cells (Fig. 5 ; 15, 16). The spherical keratin-
containing bodies of dividing cells are observed in both con-
trol and drug-treated cultures. They are found in cellsthat are
in late the phases of mitosis. However, the normal and exper-
imental modulation ofcytokeratin organization in HeLa cells
suggests that this rearrangement of keratin intermediate fila-
ments is coordinated in some way with both microfilament
and microtubule function and distribution. A dividing epithe-
lial cell may be able to circumvent possible cytoplasmic
constraints imposed by the interphase organization of cyto-
keratins by altering keratin filaments into a condensed form,
and redistributing them throughout the cytoplasm, possibly
at the cell periphery. In this sense drug treatment does not
bring aboutthe multiple site condensation ofkeratin filaments
in interphase cells seen during cell mitosis. However, it may
represent part of the physiological process of keratin filament
reorganization that goes to completion only with appropriate
cytoplasmic cues, including rearrangement of microtubules
and microfilaments, available during cell division.
Cytokeratin organization is also responsive to exogenous
biochemical cues. A transitory effect of epidermal growth
factor on keratin distribution in mouse embryonic epithelial
MMC-E cells causes a short-term keratin filament formation
different from the pre-existing condensed keratin normally
present in these cells (22). This suggests that the regulation of
cytokeratin organization can function in both directions, fil-
amentous --* condensed --> filamentous and condensed -->
filamentous -> condensed, and can be influenced by external
as well as internal triggering mechanisms. That a number of
epithelial cell types, including HeLa cells, can modulate the
organization of the keratin cytoskeleton is also indicated by
the reversibility of the combined effects ofcytochalasin D and
colchicineafterwithdrawalofthese drugs(data not presented).
A key organizational difference between cytokeratins and
other intermediate filaments is the interaction of the keratins
(tonofilaments) with desmosomes and related structures (5,
6, 11, 23-26). Our results show that cytokeratin organization
in HeLa cells depends on interactions with cell membrane
structures which provide a peripheral network of stabilizing
attachment sites for keratin filaments, as well as with micro-
tubulesand microfilaments, which may provide a cytoplasmic
framework. Other workers have reported the possibility that
nuclear membrane sites may also be involved in cytokeratin
organization (12). Sites for cell membrane-keratin association
serve two major purposes in epithelial cells: one as intercel-
lular or cell-substratum adhesive sites (macula adhaerens,
hemidesmosomes) and the other as intracellular sites for
attachment of tonofilaments in the cytoplasm, which estab-
lishes a network offilaments potentially capable of distribut-
ing stress within and between groups of cells. The lattice of
keratin filaments in drug-treated cells appears to be connected
to these focal points to form the star-like patterns observed
(Figs. 2 e and 3). It appears that the association ofcytokeratins
with membrane plaques may be crucial to filament organi-
zation and function in epithelial cells. No analogous organi-
zational structures have been described for the remaining
classes of intermediate filaments (5). With regard to interac-
tion between the nucleus and keratins, it has been reported
that keratin polypeptides are organized as filaments at a
specific site or sites on or in the nuclear membrane in vitro
(12). Both cell membrane and nuclear membrane sites may,
therefore, function to organize and maintain the distribution
of keratin filaments. Conversely, cytokeratin may function in
positioningthe nucleus in the cytoplasm (5, 6). Microinjection
of a-keratin antibodies into the cell cytoplasm of cultured
epithelial cells can result in the dissociation of keratin fila-
ments from cell and nuclear membranes and the disorgani-
zation of the keratin cytoskeleton (2, 12). Microinjection of
antibody provides an unique tool for directly and specifically
effecting cytokeratin organization only, since no exogenously
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proach, in conjunction with specific inhibition of other ele-
ments of the cytoskeleton with which the keratins interact,
adds greatly to our ability to experimentally manipulatestruc-
tural and functional interactions among the cytoskeletal ele-
ments so far implicated in keratin filament organization.
Thus, loss of microtubules and microfilaments results in an
organization of cytokeratins that is dependent on the distri-
bution of stable keratin filament-membrane attachmentsites.
These cell membrane sites are proposed to be desmosomal
structures. Antibodies to desmosomal proteins are localized
at keratin filament-membrane attachment sites observed in
drug-treated cells (unpublished observations). The nature of
nuclear membrane association sites is not known. The sug-
gestion that desmosomal-type structures are involved in sta-
bilization of keratin organization in drug-treated cells is sup-
ported by previous reports of the distribution of antidesmo-
somal protein antiserum staining on the basal surface of
cultured epithelial cells (27, 28), which is similar in distribu-
tion to focal centers in drug-treated cells (17), the pattern of
keratin filaments in relation to the periodic distribution of
intercellular connections between apposed epithelial cells (11,
17, 28), and the redistribution of desmosomal structures in
epithelial cells injected with antikeratin antibodies (11). A
further possibility that deserves exploration is that keratin
filament-membrane attachment sites, like desmosomes or
hemidesmosomes, may act not only as a system oforganiza-
tion and stabilization sites for the distribution of tonofila-
ments in interphase cells, but may potentially be structurally
involved in cyclic redistribution of keratin into spheroidal
bodies for use by daughter cellsduring and after cell division.
The organization of keratin filaments is no longer consid-
ered static in epithelial cells. The study of the coordinated
interactions of cytokeratins with microtubules/microfila-
ments and membrane attachment sites not only provides a
new experimental approach for establishing the role(s) of
keratin filaments in epithelial cells, but also focuses attention
on understanding the role(s) of all classes of intermediate
filaments in the structure and function of the vertebrate
cytoskeleton.
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